<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000908401
<NAME>                        Glyko Biomedical Ltd.
<MULTIPLIER>                  1
<CURRENCY>                    US Dollars

<S>                             <C>
<PERIOD-TYPE>                3-Mos
<FISCAL-YEAR-END>            DEC-31-2000
<PERIOD-START>               APR-01-2000
<PERIOD-END>                 JUN-30-2000
<EXCHANGE-RATE>              1
<CASH>                       1931626
<SECURITIES>                 0
<RECEIVABLES>                0
<ALLOWANCES>                 0
<INVENTORY>                  0
<CURRENT-ASSETS>             1931626
<PP&E>                      0
<DEPRECIATION>              0
<TOTAL-ASSETS>              25765148
<CURRENT-LIABILITIES>       413051
<BONDS>                     0
       0
                 0
<COMMON>                    22321124
<OTHER-SE>                  3030973
<TOTAL-LIABILITY-AND-EQUITY> 25765148
<SALES>                     0
<TOTAL-REVENUES>            14715
<CGS>                       0
<TOTAL-COSTS>               80266
<OTHER-EXPENSES>            2180712
<LOSS-PROVISION>            0
<INTEREST-EXPENSE>          0
<INCOME-PRETAX>             (2246263)
<INCOME-TAX>                (2246263)
<INCOME-CONTINUING>         (2246263)
<DISCONTINUED>              0
<EXTRAORDINARY>             0
<CHANGES>                   0
<NET-INCOME>                (2246263)
<EPS-BASIC>                 (.07)
<EPS-DILUTED>               (.07)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission